Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 2:31 AM
Ignite Modification Date: 2025-12-25 @ 2:31 AM
NCT ID: NCT02233634
Eligibility Criteria: Inclusion Criteria: * Patients with known relevant coronary artery stenosis (defined by previous coronary angiography, QCA: reduction in lumen-diameter of the vessel \>50%) with a scheduled intervention or operation to treat this stenosis (staged PCI or coronary artery bypass surgery) * CMR feasible prior to intervention or surgery * Age ≥18 years * Written informed consent * For healthy participants: Absence of cardiovascular and lung disease, and absence of medication with cardiovascular effects * Absence of exclusion criteria Exclusion Criteria * General Contraindication against MRI-Scans: (claustrophobia, ferromagnetic implants, clips, pacemakers, shrapnels, ophthalmic metal deposits) * Pregnancy or inconclusive test result * Age \<18 years * Inability to give informed consent * Consumption of caffeine, tea, treatment of dipyridamol \<12h before the scan * Medication with calcium antagonists (ok, if can be paused on the day of the scan) * Constant medication with nitrates (ok, if can be paused on the day of the scan) * Medication with methyl-xanthines * Acute myocardial ischemia/myocardial infarction * Previous Coronary Bypass Surgery * Pulmonary Disease * Enrolment of the investigator, his/her family members, employees and other dependent persons * Presence of cardiac or lung disease for healthy volunteers, nicotine consumption within the last 6 months
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT02233634
Study Brief:
Protocol Section: NCT02233634